Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...
The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...
11h
Futurism on MSNEvidence Is Growing That Ozempic Can Cause BlindnessAs drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
7h
US Weekly on MSNInfluencer Claudia Oshry Says She Used Ozempic ‘As a Tool to Change My Life’ Before PregnancyInfluencer and podcast maven Claudia Oshry used Ozempic to kickstart a newfound wellness journey.
6h
Hosted on MSNOzempic Shows Potential for Alcohol Addiction in TrialWeekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
15h
ZME Science on MSNOzempic Users Are Drinking Less Alcohol Without Even TryingIn a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results